Abstract
Coronary artery disease (CAD) remains the leading cause of morbidity and mortality in the western world. Early detection and risk stratification of underlying (CHD) is a major step in clinical decision-making. As discussed in the other chapters, myocardial perfusion imaging (MPI) using thallium-201(Tl-201) or technetium- 99m (Tc-99m) sestamibi or tetrofosmin, is used in various clinical settings to provide invaluable information on myocardial perfusion, left ventricular volumes and left ventricular function, and prognosis. MPI has the ability to localize hemodynamically important coronary stenosis; thus yielding positive results by increasing demand myocardial ischemia during exercise or inducing inhomogeneous distribution of radiotracers during pharmacological stress testing with dipyridamole or adenosine [1].
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Klocke FJ, Baird MG, Lorell BH et al. (2003) ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 Guidelines for the Clinical Use of Cardiac Radionuclide Imaging). American College of Cardiology Web Site. Available at: http://www.acc.org/clinical/guidelines/radio/index.pdf. Accessed June 04, 2006.
Gibbons RJ, Chatterjee K, Daley J et al. (2002) ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Chronic Stable Angina Guidelines). American College of Cardiology Web Site. Available at:http://www.acc.org/clinical/guidelines/stable/stable_clean.pdf. Accessed June 4, 2006.
Koller D (2002) Assessing diagnostic performance in nuclear cardiology. J Nucl Cardiol 9(1):114–123.
Brindis RG, Douglas PS, Hendel RC, Peterson ED et al. (2005) ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association. J Am Coll Cardiol 46(8):1587–1605.
Iskander S, Iskandrian AE (1998) Risk assessment using singlephoton emission computed tomographic technetium-99m sestamibi imaging. J Am Coll Cardiol 32:57–62.
Brown KA (1991) Prognostic value of thallium-201 myocardial perfusion imaging: a diagnostic tool comes of age. Circulation 83:363–381.
Brown K (1996) Prognostic value of myocardial perfusion imaging: state of the art and new developments. J Nucl Cardiol 3:516.
Little WC, Constantinescu M, Applegate RJ (1988) Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease? Circulation 78(5Pt 1):1157–1166.
Hasdai D, Gibbons RJ, Holmes DR Jr, Higano ST, Lerman A (1997) Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96(10):3390–3395.
Schwartz RG, Pearson TA, Kalaria VG et al. (2003) Prospective serial evaluation of myocardial perfusion and lipids during the first six months of pravastatin therapy: coronary artery disease regression single photon emission computed tomography monitoring trial. J Am Coll Cardiol 42:600–610.
Hachamovitch R, Hayes S, Friedman JD et al. (2003) Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans. What is the warranty period of a normal scan? J Am Coll Cardiol 41:1329.
Zellweger MJ, Dubois EA, Lai S, et al. (2002) Risk stratification in patients with remote prior myocardial infarction using rest-stress myocardial perfusion SPECT: prognostic value and impact on referral to early catheterization. J Nucl Cardiol 9:23–32.
Sharir T, Germano G, Kang X et al. (2001) Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 42: 831–837.
Leslie WD, Tully SA, Yogendran MS et al. (2005) Prognostic value of lung sestamibi uptake in myocardial perfusion imaging of patients with known or suspected coronary artery disease. J Am Coll Cardiol 45(10):1676–1682.
Abidov A, Bax JJ, Hayes SW et al. (2003) Transient ischemic dilation ratio of the left ventricle is a significant predictor of future cardiac events in patients with otherwise normal myocardial perfusion SPECT J Am Coll Cardiol 42(10):1818-1825.
Braunwald E, Antman E, Beasley J, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina); Available at: http://www.acc.org/clinical/guidelines/unstable/unstable.pdf. Accessed June 04, 2006.
Udelson JE, Beshansky JR, Ballin DS, et al. (2002) Myocardial perfusion imaging for evaluation and triage of patients with suspected acute cardiac ischemia: a randomized controlled trial. J Am Med Assoc 288:2693–2700.
Wackers FJTh, Brown KA, Heller GV et al. (2002) American Society of Nuclear Cardiology position statement on radionuclide imaging in patients with suspected acute ischemic syndromes in the emergency department or chest pain center. Am J Nucl Cardiol 9:246–250.
Dakik HA, Hwang WS, Jafar A, Kimball K, Verani MS, Mahmarian JJ (2005) Prognostic value of quantitative stress myocardial perfusion imaging in unstable angina patients with negative cardiac enzymes and no new ischemic ECG changes. J Nucl Cardiol 12:32–36.
Dakik HA, Mahmarian JJ, Kimball KT et al. (1996) Prognostic value of exercise thallium-201 tomography in patients treated with thrombolytic therapy during acute myocardial infarction. Circulation 94:2735–2742.
Travin MI, Dessouki A, Cameron T, Heller GV (1995) Use of exercise technetium-99m sestamibi SPECT imaging to detect residual ischemia and for risk stratification after acute myocardial infarction. Am J Cardiol 75:665–669.
Brown KA, Heller GV, Landin RS et al. (1999) Early dipyridamole 99mTc-sestamibi single photon emission computed tomographic imaging 2 to 4 days after acute myocardial infarction predicts in-hospital and postdischarge cardiac events: comparison with submaximal exercise imaging. Circulation 100:2060–2066.
Mahmarian JJ, Mahmarian AC, Marks GF, Pratt CM, Verani MS (1995) Role of adenosine thallium-201 tomography for defining long-term risk in patients after acute myocardial infarction. J Am Coll Cardiol 25:1333–1340.
Ellis SG, Mooney MR, George BS et al. (1992) Randomized trial of late elective angioplasty versus conservative management for patients with residual stenoses after thrombolytic treatment of myocardial infarction. Treatment of Post Thrombolytic Stenoses (TOPS) Study Group. Circulation 86:1400–1406.
Beller GA (2004) Nuclear cardiology in randomized multicenter clinical trials. J Nucl Cardiol 11(3):235–236.
Eagle KA, Coley CM, Newell JB et al. (1989) Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Internal Med 110(11):859–866.
Wackers FJ, Young LH, Inzucchi SE et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27(8):1954–1961.
Derfler K, Kletter K, Balcke P, Heinz G, Dudczak R (1991) Predictive value of thallium-201-dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients. Clin Nephrol 36(4):192–202.
Kwok YS, Kim C, Grady D et al. (1999) Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol 83:660–666.
Mieres JH, Shaw LJ, Hendel RC et al. (2003) A report of the American Society of Nuclear Cardiology Task Force on Women and Heart Disease (Writing Group on Perfusion Imaging in Women). J Nucl Cardiol 10:95–101.
Hachamovitch R, Berman DS, Kiat H et al. (1996) Effective risk stratification using exercise myocardial perfusion SPECT in women: gender-related differences in prognostic nuclear testing. J Am Coll Cardiol 28:34–44.
Amanullah AM, Kiat H, Friedman JD et al. (1996) Adenosine technetium-99m sestamibi myocardial perfusion SPECT in women: diagnostic efficacy in detection of coronary artery disease. J Am Coll Cardiol 27:803–809.
Marwick TH, Shaw LJ, Lauer MS et al. (1999) The noninvasive prediction of cardiac mortality in men and women with known or suspected coronary artery disease. Economics of Noninvasive Diagnosis (END) Study Group. Am J Med 106:172–178.
Iskandrian AS, Heo J, Kong B, Lyons E (1989) Effect of exercise level on the ability of thallium-201 tomographic imaging in detecting coronary artery disease: analysis of 461 patients. J Am Coll Cardiol 14:1477–1486.
Miller TD, Gersh BJ, Christian TF et al. (1995) Limited prognostic value of thallium-201 exercise treadmill testing early after myocardial infarction in patients treated with thrombolysis. Am Heart J 130(2):259–266.
Benoit Th, Vivegnis D, Lahiri A et al. (1996) Tomographic myocardial imaging with technetium-99m tetrofosmin. Eur Heart J 17:635–642.
Daou D, Delahaye N, Lebtahi R et al. (2000) Diagnosis of extensive coronary artery disease: intrinsic value of increased lung Tl-201 uptake with exercise SPECT. J Nucl Med 41:567–574.
Ho K-T, Miller TD, Christian TF et al. (2001) Prediction of severe coronary artery disease and long-term outcome in patients undergoing vasodilator SPECT. J Nucl Cardiol 8:438–444.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ghanem, F., Movahed, A. (2009). Myocardial Perfusion Imaging for Risk Stratification in Suspected or Known Coronary Artery Disease: Current Status and Limitations. In: Movahed, A., Gnanasegaran, G., Buscombe, J., Hall, M. (eds) Integrating Cardiology for Nuclear Medicine Physicians. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-78674-0_20
Download citation
DOI: https://doi.org/10.1007/978-3-540-78674-0_20
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-78673-3
Online ISBN: 978-3-540-78674-0
eBook Packages: MedicineMedicine (R0)